Vaccine Contract Manufacturing Market
According to Intent Market Research, the Vaccine Contract Manufacturing Market is expected to grow from USD 1.9 billion in 2023 at a CAGR of 8.8% to touch USD 3.5 billion by 2030. The Vaccine Contract Manufacturing Market is dominated by key players such as Bausch Health, Boehringer Ingelheim, Catalent, Inc., CordenPharma, Emergent BioSolutions, GlaxoSmithKline, Lonza Group AG, Recipharm AB, Samsung Biologics, Sanofi Pasteur, Serum Institute of India, Takeda Pharmaceutical Company, Vaccines Manufacturing, Inc. (VMI), Vetter Pharma International, WuXi AppTec.